普洛药业 (000739.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(普洛药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年第三季度2023年第二季度2023年第一季度2022年第四季度2022年第三季度2022年第二季度2022年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 2,545,629,776.072,868,917,008.493,085,538,744.522,994,100,993.702,565,126,389.012,884,249,169.152,101,428,825.31
 营业收入(元) 2,545,629,776.072,868,917,008.493,085,538,744.522,994,100,993.702,565,126,389.012,884,249,169.152,101,428,825.31
二、营业总成本(元) 2,252,497,747.622,464,511,877.462,727,579,280.842,713,000,452.732,282,015,641.442,531,636,275.511,941,837,609.45
 营业成本(元) 1,853,135,871.252,147,789,714.002,222,844,353.532,313,197,069.691,975,504,451.612,195,431,756.121,540,095,634.47
 研发费用(元) 131,960,965.69149,553,994.28202,240,389.62127,912,788.89122,644,432.78140,084,740.00142,277,701.47
 营业税金及附加(元) 10,524,311.6013,402,401.5413,477,733.086,431,311.558,417,320.707,419,544.159,494,827.70
 销售费用(元) 162,344,017.67132,763,009.99134,825,818.51140,270,886.82132,343,714.80137,352,636.00125,296,040.38
 管理费用(元) 113,584,208.28107,550,919.88136,777,997.77105,558,652.62117,001,217.93110,961,683.15116,542,533.28
 财务费用(元) -19,051,626.87-86,548,162.2317,412,988.3319,629,743.16-73,895,496.38-59,614,083.918,130,872.15
  其中:利息费用(元) 10,305,867.198,657,249.098,551,272.548,280,631.227,598,723.928,394,414.134,963,930.53
  其中:利息收入(元) 34,912,425.0822,692,404.799,923,292.1427,082,102.3818,936,384.7916,442,093.2013,374,294.05
 资产减值损失(元) -24,225,717.934,579,309.04-40,497,637.55-46,798,340.82-366,355.41-3,829,860.84-163,242.10
 信用减值损失(元) 12,903,188.059,018,574.48-19,493,117.59-15,881,310.888,274,941.12-19,615,777.84915,373.39
三、其他经营收益
 加:公允价值变动收益(元) -10,115,550.34-17,678,570.354,192,034.1455,871,377.65-31,215,737.82-43,451,679.82-4,041,823.60
 加:投资收益(元) -2,865,390.456,644,264.73-7,432,195.11-34,414,107.63-28,368,297.68-6,447,405.199,461,798.73
  其中:对联营企业和合营企业的投资收益(元) -77,219.154,778,670.76-4,327,268.592,233,382.19421,400.02273,848.241,230,802.40
 资产处置收益(元) 17,493.76--973,373.73224,158.02-174,914.46
 其他收益(元) 35,748,524.285,750,916.081,475,758.744,963,921.4024,376,326.8950,156,065.8314,408,816.36
四、营业利润(元) 304,594,575.82412,726,105.28296,204,306.31245,815,454.42256,035,782.69329,424,235.78180,347,053.10
 加:营业外收入(元) 877,185.731,000,615.22291,284.391,070,089.441,497,233.28917,151.732,453,820.08
 减:营业外支出(元) 8,134,101.62934,263.521,931,011.31782,609.791,020,492.222,780,120.50912,464.66
五、利润总额(元) 297,337,659.93412,792,456.98294,564,579.39246,102,934.07256,512,523.75327,561,267.01181,888,408.52
 减:所得税费用(元) 47,067,287.2051,056,342.8855,256,572.95-85,976,622.2536,406,063.4142,668,100.7229,796,752.46
六、净利润(元) 250,270,372.73361,736,114.10239,308,006.44332,079,556.32220,106,460.34284,893,166.29152,091,656.06
(一)按经营持续性分类
  持续经营净利润(元) 250,270,372.73361,736,114.10239,308,006.44332,079,556.32220,106,460.34284,893,166.29152,091,656.06
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 250,278,752.86361,755,404.64239,309,926.36331,895,859.65220,292,993.64284,893,166.29152,091,656.06
  少数股东损益(元) -8,380.13-19,290.54-1,919.92183,696.67---
 扣除非经常性损益后的净利润(元) 232,777,097.18361,377,050.55233,618,771.10173,190,264.43244,796,455.99282,419,164.93135,904,532.94
七、每股收益
 一、基本每股收益(元) 0.210.310.200.280.190.240.13
 二、稀释每股收益(元) 0.210.310.200.280.190.240.13
八、其他综合收益(元) -4,744.22-3,385,037.47294,088.26150,838.18-842,336.45-542,415.5614,776.38
 归属于母公司股东的其他综合收益(元) -4,744.22-3,385,037.47294,088.26150,838.18-842,336.45-542,415.5614,776.38
九、综合收益总额(元) 250,265,628.51358,351,076.63239,602,094.70332,230,394.50219,264,123.89284,350,750.73152,106,432.44
 归属于母公司所有者的综合收益总额(元) 250,274,008.64358,370,367.17239,604,014.62332,046,697.83219,450,657.19284,350,750.73152,106,432.44
 归属于少数股东的综合收益总额(元) -8,380.13-19,290.54-1,919.92183,696.67---
公告日期 2023-10-192023-08-152023-04-182023-03-102022-10-202022-07-282022-04-27
审计意见(境内) 标准无保留意见

前瞻产业研究院